DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Bazinet M, Pantea V, Cebotarescu V. et al.
Establishment of persistent functional remission of HBV and HDV infection following REP 2139 and pegylated interferon alpha 2a therapy in patients with chronic HBV/HDV co-infection: 18 month follow-up results from the REP 301-LTF study.
Journal Of Hepatology 2018;
68: S509
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.